Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZDHHC20 pseudogene 4 (abbreviated ZDHHC20P4) appears to be a non-functional pseudogene related to the ZDHHC20 gene. Pseudogenes are genomic DNA sequences similar to normal genes but unable to encode functional proteins, usually due to mutations, incomplete sequences, or gene rearrangements. There is no documentation of ZDHHC20P4 acting as an enzyme, receptor, transporter, or having any described molecular activity. The relevant functional gene, ZDHHC20 (ZDHHC palmitoyltransferase 20), is known for mediating S-palmitoylation of proteins, is implicated in cancer biology, and may act as a therapeutic target for hepatocellular carcinoma and other malignancies[1][2][3]. However, ZDHHC20P4 lacks evidence of protein expression, biological function, disease relevance, or drug interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZDHHC20 pseudogene 4 (ZDHHC20P4).